2023Research article
Phytochemical, GC-MS, FTIR and Amino acid profile of methanol extract of Tetrapleura tetraptera fruit.
Journal of Drug Delivery and Therapeutics
18+ citationsView details
Open to Research Collaboration
Discovering therapeutic potentials through experimental and computational bioscience.
CLINX Research & Biosciences is an independent bioscience research company integrating experimental biochemistry, toxicology, phytochemistry, and computational bioscience to investigate medicinal plants and natural bioactive compounds. Through laboratory experimentation and computational analysis, we generate reproducible scientific evidence that supports future therapeutic discovery and collaborative research.
Experimental. Computational. Translational.
Our Research Programmes
Evidence. Discovery. Translation.
Our research combines experimental biochemistry, toxicology, phytochemistry and computational bioscience to investigate natural products with therapeutic potential. Each programme contributes to a unified framework for evidence generation, publication and future translational research.
Toxicology & Safety Evaluation
Comprehensive in vitro and in silico toxicity profiling for preclinical safety.
Medicinal Plant & Product Research
Bioactive compound extraction, characterization, and efficacy studies of botanicals.
Nutritional & Molecular Biochemistry
Investigating cellular nutrients and metabolic pathways at the molecular level.
Metabolomics
Profiling small molecule metabolites to map biological states and responses.
Computational Bioscience & Drug Discovery
Accelerating candidate identification through molecular modeling and bioinformatics.
In-silico Pharmacology
Modeling drug behavior, kinetics, and interactions at a systems level.
Network Pharmacology
Mapping compound–target–pathway–disease relationships to prioritize multi-target hypotheses.
Translational Therapeutics
Bridging preclinical discovery and early clinical validation blueprints.
About CLINX
Independent bioscience. Reproducible evidence.
CLINX is an independent bioscience research firm focusing on experimental biochemistry, toxicology, phytochemistry, and computational biology to explore natural products and biological mechanisms. Our research combines laboratory experimentation with computational analysis to produce solid scientific evidence that supports therapeutic discovery, publication, and scientific collaboration.
- Experimental biochemistry
- Computational bioscience
- Natural product research
- Reproducible evidence
25+
Scientific Platforms
57+
Research Citations
100+
Experimental Parameters Evaluated
Ramsgate, Kent
United Kingdom
The CLINX Research Framework
Our structured research workflow
Our research follows a structured methodology integrating experimental biochemistry, toxicological assessment, and computational bioscience to investigate medicinal plants and natural bioactive compounds, generating robust, reproducible scientific evidence that supports future therapeutic discovery.
01
Hypothesis
Identify an important scientific question.
02
Natural Product Selection
Select promising medicinal plants or natural compounds.
03
Experimental Biochemistry
Test biological activity through laboratory experiments.
04
Toxicological Assessment
Assess safety and potential toxic effects.
05
Computational Bioscience
Predict molecular interactions using computational methods.
06
Biological Interpretation
Integrate findings to understand biological significance.
07
Scientific Publication
Share reproducible findings with the scientific community.
08
Future Therapeutic Research
Inform future therapeutic discovery and collaborative research.
Toxicology & Safety Evaluation
Modelling drug toxicity computationally
Predictive ADMET profiling plots lipophilicity (WLOGP) against topological polar surface area (TPSA) to indicate how a compound is likely to be absorbed and distributed, informing safety assessment before laboratory testing begins.
Our Computational Research Ecosystem
CLINX combines globally recognised scientific databases, molecular modelling platforms, and predictive analytics tools to support evidence-based bioscience research — from target identification to biological interpretation.
Structural Biology
AlphaFoldPDBUniProtSWISS-MODELInterPro
Chemical Biology
PubChemChEMBLDrugBankCOCONUTKEGG
ADMET & Systems
SwissADMEpkCSMProTox-3STRING
Molecular Modelling
AutoDock VinaPyRxPyMOLUCSF ChimeraX
Computational analyses are integrated with experimental evidence and scientific review. Platform availability varies according to project requirements.
Scientific Disclaimer: Computational predictions complement experimental research and inform hypothesis generation; they do not replace laboratory validation or clinical investigation.
Publications & Research Portfolio
Research portfolio
Peer-reviewed founder publications, collaborative manuscripts under review, and active CLINX research programmes.
01 · Founder Publications
Founder publications
Peer-reviewed publications authored by the founder before the establishment of CLINX Research & Biosciences.
Lead Author (2) · Co-author (2)
2023Research article
GCMS and FTIR analysis of ethanol and methanol leave extract of Urena lobata (Caesar weed) for bioactive phytochemical constituents
Journal of Drug Delivery and Therapeutics
31+ citationsView details
2022Research article
Renal function parameters and hematological indices among artisans occupationally exposed to Lead in Suleja metropolis, Nigeria.
Research Journal in Medical and Health Sciences
2+ citationsView details
2023Research article
Phytochemical and nutritional composition of ethanol-water leaf extracts of Justicia secunda and Jatropha tanjorensis.
GSC Biological and Pharmaceutical Sciences
6+ citationsView details
02 · Collaborative Research Under Review
Collaborative research under review
Manuscripts co-authored with research partners, currently undergoing international peer review.
Under peer reviewCo-author (6th Author)
Multiscale Computational Modelling of Host-Pathogen Immune Dynamics
Journal: Journal of Molecular Modeling
Under peer reviewCo-author (6th Author)
Stimuli-Response Nanotherapeutic Strategies for Metabolic Disease Research.
Journal: In Silico Pharmacology (Springer)
03 · CLINX Research Programmes
Current CLINX research programmes
Founder-designed research conducted under CLINX Research & Biosciences.
4 active programmes
Programme 1Active research programme
Natural Product Discovery for Metabolic Disease Targets
Experimental Biochemistry. Computational Bioscience. Molecular Docking.
Experimental and computational investigation of naturally occurring bioactive compounds for enzyme targets associated with metabolic disorders. Detailed methodologies and findings will be disclosed following publication.
Programme 2Active research programme
Comparative Antioxidant and Safety Evaluation of Therapeutic Natural Product
Biochemistry. Toxicology. Natural Product Research.
Comparative evaluation of antioxidant capacity and preliminary safety profiles of selected medicinal plant candidates to support evidence-based natural product research.
Programme 3Active research programme
Structure-Based Investigation of Opioid Receptor Interactions
Structural Biology. Molecular Dynamics. Computational Pharmacology.
Applying molecular dynamics simulations and structural modelling to investigate receptor-ligand interaction networks relevant to pain pharmacology.
Programme 4Active research programme
Virtual Screening of Brain-Penetrant Natural Product Candidates
Virtual Screening. ADMET Prediction. Molecular Docking.
Screening naturally derived compounds using computational approaches to identify candidates with favourable predicted central nervous system properties.
Research Collaboration
Discuss Your Project
Whether you're planning a new study, strengthening an existing research programme, or seeking independent computational and experimental expertise, CLINX is prepared to collaborate with academic, biotechnology, and healthcare partners.